Four patients with minocycline-induced cutaneous pigmentation were treated with the Q-switched ruby laser. The pigmentation resolved and there was no adverse effects.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Platelet-Rich Plasma Injection Combined With Q-Switched Ruby Laser in the Treatment of Periorbital Hyperpigmentation.
J Cosmet Dermatol
September 2024
Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
Article Synopsis
- Periorbital hyperpigmentation is a common skin issue often seen in cosmetic dermatology, particularly as a lingering problem after Q-switched ruby laser treatments.
- This study aimed to compare the effectiveness of combining platelet-rich plasma (PRP) injections with laser therapy versus using laser treatment alone for this condition.
- Results showed that the combination therapy improved long-term outcomes, increased patient satisfaction, and reduced the risk of further pigmentation issues, offering a promising new treatment option.
Drug-Induced Pigmentation: A Review.
Drugs
September 2024
Department of Dermatology, Henry Ford Health, 3031 W Grand Blvd, Detroit, MI, 48202, USA.
Article Synopsis
- * A comprehensive physical examination and medication history are crucial for identifying the specific offending drug, as DIP typically results from melanin accumulation or drug and iron deposition in the skin.
- * Preventive measures like using broad-spectrum sunscreen and photoprotective clothing are important, and various laser treatments have shown effectiveness in clearing DIP.
Early Treatment of Nevus of Ota in Children is More Effective and Beneficial to Mental Health: Observation on the Efficacy of Q-Switched Ruby Laser in Treating 159 Cases of Nevus of Ota in Children.
Clin Cosmet Investig Dermatol
June 2024
Department of Dermatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, 325027, People's Republic of China.
Article Synopsis
- Nevus of Ota (NO) is a harmless skin pigmentation often treated with Q-switched ruby laser, but the best age for treatment remains debated, prompting a study on its effectiveness and psychological impact on children of different ages.* -
- The research analyzed children treated between 2015 and 2019, revealing that preschoolers (aged 0-7) had a 93.1% treatment success rate with fewer sessions (3.6 on average) and lower adverse reactions (4.7%) compared to school-age children (aged 7-14) who had a 90.3% success rate but needed more treatments (5.1 average) and faced higher adverse reactions (13.7%).* -
Treatment of pigmented fungiform papillae of the tongue with 694 nm Q-switched ruby laser.
Lasers Surg Med
April 2024
Laser & Skin Surgery Center of New York, New York, New York, USA.
A focused review of visible light therapies for vitiligo.
Photodermatol Photoimmunol Photomed
January 2024
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Background: Vitiligo can be challenging to treat and exhibit an unpredictable clinical course. Phototherapy in the form of visible light can achieve both repigmentation and depigmentation outcomes in vitiligo, with minimal associated adverse events. This review focuses on the mechanistic understandings and clinical outcomes of visible light-based treatments for vitiligo.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!